R&D Platform
Technology Platforms · IP · Collaboration Models
Technology Platforms
微生物及病原研究平台
微生物分离鉴定、病原生物学与抗感染评价体系。
药物分子与制剂研发平台
先导化合物筛选、分子优化与制剂工艺开发。
疫苗构建与免疫评价平台
新型抗原构建、佐剂体系与临床前免疫评价。
功能食品活性物质评价平台
药食同源活性成分筛选、配方开发与安全评价。
Intellectual Property
Patent portfolio covering drug molecules, vaccine technologies and functional formulas, open for technology transfer and licensing.
一种抗感染先导化合物及其制备方法
新型抗原设计递送体系
药食同源功能配方及其稳定性工艺
微生物组营养评价方法
Partnership Models
Joint R&D
Shared investment, shared outcomes
Contract Research
We deliver your R&D programmes
Technology Licensing
Patent and technology transfer
Industrialisation
Manufacturing, registration and market access
R&D Pipeline
Focused on unmet clinical and health needs, advancing each candidate steadily.
🧪Innovative Drugs
GLB-001GLB-001 Anti-infective Candidate
Novel anti-MDR small molecule; key efficacy studies completed.
GLB-002GLB-002 Metabolic-inflammatory Modulator
Lead optimisation targeting metabolic-inflammatory pathways.
💉Vaccines
GLV-101GLV-101 Novel Antigen Vaccine
Antigen design completed; IND filing in progress.
GLV-102GLV-102 Adjuvant Platform
Broad-spectrum adjuvant system construction and evaluation.
🌿Functional Food & Health Products
GLF-201GLF-201 Function Formula
First functional dietary product launched in GBA market.
GLF-202GLF-202 Microbiome Nutrition Series
Formulation finalised; scale-up and registration ongoing.